True North appoints CMO, raises $22m
This article was originally published in Scrip
Executive Summary
Californian biotech company True North Therapeutics has appointed Dr James Gilbert chief medical officer, and raised $22m in its series A financing round to enable it to move its lead candidate into the clinic. True North is developing novel therapies that selectively inhibit the complement system to treat rare diseases.